Zoledronic acid, a powerful bisphosphonate, significantly decreases acute bone loss following transplants. It is administered 7 days after transplantation and then at the end of the first, third, sixth and ninth months after transplantation 1, 65.
El ácido zoledrónico, un potente bifosfonato, dado al plazo de 7 días postrasplante y luego a los 1, 3, 6 y 9 meses reduce de manera significativa la pérdida aguda de masa ósea 1, 65.